Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 181.15m |
Free float | 172.52m |
P/E (TTM) | -- |
Market cap | 171.91m SEK |
EPS (TTM) | -1.30 SEK |
Data delayed at least 20 minutes, as of Mar 21 2024.
More ▼
Press releases
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health
- Immunovia files US patent application to protect its next-generation test
- Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
- Invitation to Immunovia's Q2 presentation
- Immunovia presents data from discovery study at 2024 PancreasFest medical conference
- Immunovia's new lab staffed and operational after rapid implementation
More ▼